Andrew Cooper
Stock Analyst at Raymond James
(2.35)
# 2,607
Out of 4,996 analysts
147
Total ratings
43.51%
Success rate
-1.14%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $48.17 | +61.93% | 10 | Aug 11, 2025 | |
| AZTA Azenta | Upgrades: Outperform | $35 | $28.54 | +22.63% | 2 | Aug 6, 2025 | |
| AVTR Avantor | Reiterates: Outperform | $16 → $14 | $11.84 | +18.24% | 15 | Aug 4, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $60.03 | +1.62% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $84.06 | +36.81% | 9 | Jul 29, 2025 | |
| ITGR Integer Holdings | Maintains: Outperform | $150 → $143 | $101.50 | +40.89% | 3 | Jul 25, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $464.24 | +15.24% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $7.70 | +29.87% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $22.59 | +10.67% | 2 | May 5, 2025 | |
| HOLX Hologic | Reiterates: Outperform | $90 → $71 | $67.21 | +5.64% | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $193.54 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $184.84 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $53.57 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.94 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $162.97 | -47.84% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $28.33 | +168.27% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.40 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.93 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $33.44 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.20 | - | 5 | Sep 22, 2021 |
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $48.17
Upside: +61.93%
Azenta
Aug 6, 2025
Upgrades: Outperform
Price Target: $35
Current: $28.54
Upside: +22.63%
Avantor
Aug 4, 2025
Reiterates: Outperform
Price Target: $16 → $14
Current: $11.84
Upside: +18.24%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $60.03
Upside: +1.62%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $84.06
Upside: +36.81%
Integer Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $150 → $143
Current: $101.50
Upside: +40.89%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $464.24
Upside: +15.24%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $7.70
Upside: +29.87%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $22.59
Upside: +10.67%
Hologic
May 2, 2025
Reiterates: Outperform
Price Target: $90 → $71
Current: $67.21
Upside: +5.64%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $193.54
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $184.84
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $53.57
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $14.94
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $162.97
Upside: -47.84%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $28.33
Upside: +168.27%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $3.40
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.93
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $33.44
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.20
Upside: -